Browse > Article

The Association between hs-CRP Concentration of Blood and Metabolic Syndrome in the Residents of a Rural Community  

Kim, Jong-Im (Department of Nursing, Daejeon Health Sciences College)
Publication Information
Korean Journal of Community Nutrition / v.15, no.6, 2010 , pp. 796-805 More about this Journal
Abstract
This study investigated the correlations and risk distribution differences between high sensitivity C-reactive protein (hs-CRP) and the diagnosis factors of metabolic syndrome among the residents of a rural community. Two thousand adults aged from 40 to 70 were recruited and 1,968 subjects were included in the study after excluding those with infectious disease or with hs-CRP higher than 10 mg/L in blood. The subjects were then divided into three groups of hs-CRP to examine the correlations and risk ratio with the risk factors of metabolic syndrome. There was a tendency of hs-CRP increasing according to the number of risk factors of metabolic syndrome. The risk ratio with hs-CRP according to metabolic syndrome significantly increased by 2.0 and 2.2 times in the intermediate and high risk group, respectively, compared with the low risk group. The risk ratio with the risk factors of metabolic syndrome according to hs-CRP rose in abdominal obesity, triglyceride, and W/Ht in the intermediate risk group of hs-CRP. The risk ratio also surged in high pressure, W/Ht, ex-drinking (1.7 times), exsmoking (2.0 times) and current smoking (2.0 times) in the high risk group. The results indicate that hs-CRP is related to the risk factors of metabolic syndrome and that it's very important to manage obesity including abdominal obesity and W/Ht and everyday habits including drinking and smoking.
Keywords
hs-CRP; metabolic syndrome; abdominal obesity;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 McNeill AM, Rosamond WD, Girman CK, Golden SH, Schmidt ML, East HE, Rhys Williams G (2005): The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28(2): 385-390   DOI   ScienceOn
2 Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M (2003): Markers of inflamation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 107(3): 499-511   DOI   ScienceOn
3 Facchini F, Chen YD, Reaven GM (1994): Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 17(2): 115-119   DOI   ScienceOn
4 Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W (2000): Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23(12): 1835-1839   DOI   ScienceOn
5 Tracy RP, Lemaitre RN, Psaty BM, Lves DG, Evans RW, Cushman M, Meilahn EN, Kuller LH (1997): Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17(6): 1121-1127   DOI   ScienceOn
6 Ridker PM, Buring JE, Cook NR, Rifai N (2003): C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107(3): 391-397   DOI   ScienceOn
7 Ridker PM, Wilson PW, Grundy SM (2004): Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109(23): 2818-2825   DOI   ScienceOn
8 Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lesperance J, Levesque S, Varga S (2004): Effect of increasing metabolic syndrome score on atherosclerotic risk profil and coronary artery disease angiographic severity. Am J Cardiol 93(2): 159-164   DOI   ScienceOn
9 Sower JR (2003): Obesity as a cardiovascular risk factors. Am J Med 115(8A): 37-44
10 Stern MP, Williams K, Haffer SM (2002): Identification of persons at high risk for type 2 diabetes mellitus: Do we need the oral glucose tolerance test? Ann Inter Med 136(8): 575-581   DOI   ScienceOn
11 Wamala SP, Lynch J, horsten M, Mittleman MA, Schench-Gustafsson K, Orth-Gomer K (1999): Education and the metabolic syndrome in women. Diabetes Care 22(12): 1999-2003   DOI   ScienceOn
12 WHO WPR (2000): The Asia-Pacific perspective: Redefining obesity and its treatment, Sydney, Australia, World Health Organization Western Pacific Region
13 Lim S, Lee HK, Kim KC, Park C, Shin C, Cho NH (2006): Submitted to journal of endocrinological investigation a ruralurban comparison of the characteristics of metabolic syndrome by gender in Korea: The Korea Health and Denome Study (KHGS). J Endocrinol Invest 29(4): 303-319
14 Park JS, Park HD, Yun JW, Jung CH, Lee WY, Kim SW (2002): Prevalence of the metabolic syndrome as defined by NCEP-APT among the urban Korean population. Korean J Med 63(3): 290-298
15 Marroquin OC, Kip KE, Kelley DE, Johnson BD, shaw LJ, Bairey Merz CN, Sharaf BL, Pepine CJ, Sopko G, Reis SE (2004): Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: A report from the women's ischemia syndrome evaluation. Circulation 109(6): 714-721   DOI   ScienceOn
16 Meshkani R, Taghikhani M, Larijani B, Khatami B, Khatami S, Khoshbin E, Adeli K (2006): The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance. Clin Chim Acta 371(2): 169-175   DOI   ScienceOn
17 Nakanishi N, shirishi T, Wada M (2005): Association between fasting glucose and C-reactive protein in a Japanese population: the Minoh study. Diabetes Research and Clinical Practice 69(1): 88-98   DOI   ScienceOn
18 Reaven GM (1998): Role of insulin resistance in human disease. Diabetes 37(12): 1595-1607
19 Roberts WL (2004): CDC/AHA wirkshop on marlers of inflammation and cardiovascular disease: Application to clinical and public health practice: laboratory tests available to assess inflammation-performance and standardization. Circulation 110(25): 572-576   DOI   ScienceOn
20 Ridker PM, Stampfer MJ, Rifai N (2001): Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285(19): 2481-2485   DOI   ScienceOn
21 Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH (2001): C-reactive protein and body mass index in children; findings from the national health and nutrition examination survery. 1998-1994. J Pediatr 138(4): 486-492   DOI   ScienceOn
22 Isomaa P, Almaren P, Tuomi T, Forsen B, Lahti K, Nissen M (2001): Cardiovascular morbidity and associated with the metabolic syndrome. Diabetes Care 24(4): 683-689   DOI   ScienceOn
23 Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N (2002): C-Reactive protein is an independent predictor of risk for the development of diabetes in the west of scotland coronary prevention study. Diabetes 51(5): 1596-1600   DOI   ScienceOn
24 Grundy SM, Cleeman JL, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F (2005): American heart association; national heart, lung, and blood institute, diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institude scientific statement. Circulation 112: 2735-2752   DOI   ScienceOn
25 Hsieh SD, Muto T (2006): Metabolic syndrome in Japanese men and women with special reference to the anthropometric criteria for the assessment of obesity: Proposal to use the waist-to-height ratio. Prev Med 42(2): 135-139   DOI   ScienceOn
26 JNC (2003): The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
27 KIMS POC (Point of Care) (2007): Current data of HDL in Korean and new proposal to define role of HDL in Korean. Available from http://www.kimsonline.co.kr
28 KOSSO (2005): Korean Society for the Study of Obesity
29 Kwon HS, Park YM, Lee HJ, Lee JH, Choi YH, Ko SH, Lee JM, Kim SR, Kang SY, Lee WC, Ah MS (2005): The prevalence and clinical characteristics of the metabolic syndrome in middleaged Korean adults. Korean J Med 68(4): 359-369
30 Ahn SK, Chun BY, Kam S, Jin DG, Kim JY (2002): Serum total cholesterol levels and related factors in a rural adult population. J Prev Med Pub Health 35(3): 256-262   과학기술학회마을
31 Aguilar D, Fisher MR, O'Connor CM, Dunne MW, Muhlestein JB, Yao L, Gupta S, Benner RJ, Cook TD, Edwards D, Pfeffer MA (2006): Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease. Am Heart J 152: 298-304.   DOI   ScienceOn
32 Albert MA (2000): The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep 2(4): 274-279   DOI   ScienceOn
33 Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA (1998): Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338(23): 1650-1656   DOI   ScienceOn
34 Blake GJ, Ricker PM (2003): C-reactive protein and other inflammatory risk markers in acute coronary syndrome. J Am College Cardiology 41(4): 37-42   DOI   ScienceOn
35 Castelli WP (1998): Cholesterol and lipids in the risk of coronary heart disease: The framingham heart study. Can J Cardiol 4: 5A-10A